Shailputri Pharmaceuticals (I) Private Limited
About Shailputri Pharmaceuticals (I) Private Limited
Data last updated:
Shailputri Pharmaceuticals (I) Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 02 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74994MH2018PTC307340. Its GSTIN is 23ABACS0987L1Z3 (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Shailbala Shrivastava (Managing Director) and Saumil Khare.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 102 Sanman G P No.21 – 22 Somalwada, Nagpur, Maharashtra, India – 440025.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.04 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹26,161 (net margin 0.4%) and EBITDA of ₹2.16 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 256% over five years.
Company details
Contact details
Shailputri Pharmaceuticals (I) Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 102 Sanman G P No.21 – 22 Somalwada, Nagpur, Maharashtra, India – 440025
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Shailputri Pharmaceuticals (I) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shailputri Pharmaceuticals (I) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shailputri Pharmaceuticals (I) Private Limited, buy the company report.
Financials of Shailputri Pharmaceuticals (I) Private Limited
FY 2024 filings availableShailputri Pharmaceuticals (I) Private Limited reported revenue of ₹60.04 Lakh (down 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 256%. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26,161 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shailputri Pharmaceuticals (I) Private Limited, buy the company report.
Board of directors of Shailputri Pharmaceuticals (I) Private Limited
Shailputri Pharmaceuticals (I) has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saumil Khare Also directs: Kyracure Private Limited | Director | 02 Apr 2018 | 8 Years 7 Months | Current |
| Shailbala Shrivastava | Managing Director | 02 Apr 2018 | 8 Years 7 Months | Current |
| Rakesh Indirapati Pandey | Director | 02 Apr 2018 | 8 Years 7 Months | Current |
| Adarsh Rakesh Pandey | Director | 28 May 2018 | 8 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Shailputri Pharmaceuticals (I) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shailputri Pharmaceuticals (I) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shailputri Pharmaceuticals (I) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABACS0987L1Z3 | Madhya Pradesh | Active | 14 Oct 2019 |
To see the full GST registrations and return filing status of Shailputri Pharmaceuticals (I) Private Limited, buy the company report.
Recent activity
Shailputri Pharmaceuticals (I) Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Adarsh Rakesh Pandey ceased to be Additional Director on 31 Dec 2019.
Frequently asked questions
Shailputri Pharmaceuticals (I) is an active private limited company based in Nagpur, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 02 April 2018 (8+ years old) and is registered under CIN U74994MH2018PTC307340.
Shailputri Pharmaceuticals (I) has 4 current directors:
- Shailbala Shrivastava - Managing Director
- Saumil Khare - Director
- Rakesh Indirapati Pandey - Director
- Adarsh Rakesh Pandey - Director
The latest financial statements of Shailputri Pharmaceuticals (I) on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Shailputri Pharmaceuticals (I) is 23ABACS0987L1Z3, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Shailputri Pharmaceuticals (I) is U74994MH2018PTC307340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shailputri Pharmaceuticals (I) was incorporated on 02 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Nagpur.
Adarsh Rakesh Pandey ceased to be Additional Director on 31 Dec 2019. Adarsh Rakesh Pandey was appointed as Director on 28 May 2018. Shailbala Shrivastava ceased to be Director on 28 May 2018. Shailputri Pharmaceuticals (I) has 6 board changes on record in total.
The registered office of Shailputri Pharmaceuticals (I) is at Flat No. 102 Sanman G P No.21 – 22 Somalwada, Nagpur, Maharashtra, India – 440025.
Shailputri Pharmaceuticals (I) operates in the business services industry, in the other services segment.
Shailputri Pharmaceuticals (I) can be reached at its registered office: Flat No. 102 Sanman G P No.21 – 22 Somalwada, Nagpur, Maharashtra, India – 440025.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
